Caveolin 1 (CAV1) Rabbit Polyclonal Antibody
CAT#: TA350951
Rabbit Polyclonal Anti-CAV1 Antibody
Size: 25 ul
Need it in bulk or conjugated?
Get a free quote
CNY 1,999.00
CNY 3,280.00
Cited in 1 publication. |
CNY 300.00
CNY 1,430.00
Specifications
Product Data | |
Applications | IHC, WB |
Recommend Dilution | WB: 1000-5000 WB positive control: Human fetal muscle and fetal lung tissue, Human leiomyosarcoma tissue, mouse lung and heart tissue, NIH/3T3 cells IHC: 50-200 Positive control: Human esophagus cancer Predicted cell location: Cytoplasm |
Reactivity | Human, Mouse, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Synthetic peptide of human CAV1 |
Formulation | pH7.4 PBS, 0.05% NaN3, 40% Glyceroln |
Concentration | lot specific |
Purification | Antigen affinity purification |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 20 kDa |
Gene Name | caveolin 1 |
Database Link | |
Background | The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1. |
Synonyms | BSCL3; CGL3; LCCNS; MSTP085; PPH3; VIP21 |
Reference Data | |
Protein Families | Druggable Genome, Transmembrane |
Protein Pathways | Focal adhesion, Viral myocarditis |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
Dysregulation of proangiogeneic factors in pressure-overload left-ventricular hypertrophy results in inadequate capillary growth
,Zeriouh, M;Sabashnikov, A;Tenbrock, A;Neef, K;Merkle, J;Eghbalzadeh, K;Weber, C;Liakopoulos, OJ;Deppe, AC;Stamm, C;Cowan, DB;Wahlers, T;Choi, YH;,
Ther Adv Cardiovasc Dis
,PubMed ID 31088231
[CAV1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它Caveolin 1产品